Nikolaos Giannakoulas

Author

University of Patras ORCID

Also Known As

N Giannakoulas, N. Giannakoulas, N.C. Giannakoulas, Nikolaos C. Giannakoulas, Nikolaos Giannakoulas

Publications

745

Citations

H-Index

Concepts

All Affiliations

University of Patras University of Thessaly Theageneio General Hospital Evangelismos Hospital National and Kapodistrian University of Athens

About

Nikolaos Giannakoulas is an author at University of Patras specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	386
2	Health Sciences	3	3	126
3	Immunology	3	3	101
4	Allergy	1	1	62
5	Cell Biology	1	1	26

Nikolaos Giannakoulas

Publications

547

Citations

H-Index

Page 1

	Year	Citations
A revised international prognostic score system for Waldenström’s macroglobulinemia Efstathios Kastritis, Pierre Morel, Alain Duhamel, Leukemia Prognostic EvaluationPrognostic BiomarkersMedicinePrognosisPathology	2019	104
Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients Eirini Katodritou, Evangelos Terpos, Argiris Symeonidis, American Journal of Hematology Prognostic FactorsSurgical OncologyAdjuvant ChemotherapyPathologyClinical Features	2014	67
Clinical relevance of balance between type 1 and type 2 immune responses of lymphocyte subpopulations in aplastic anaemia patients Nikolaos Giannakoulas, Maria Pagoni, Athanasios Galanopoulos, British Journal of Haematology Cd4+ CellsImmunologyBlood CellPathologyImmunotherapy	2003	62
Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group Eirini Katodritou, Evangelos Terpos, Sossana Delimpasi, Blood Cancer Journal	2018	46
Markers of Endothelial and In Vivo Platelet Activation in Patients with Essential Thrombocythemia and Polycythemia Vera Nikolaos Giannakoulas, Panagiotis Zikos, George Sakellaropoulos, International Journal of Hematology InflammationThrombosisPolycythemia VeraThrombopoiesisCardiovascular Disease	2004	44
Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents Flora Zagouri, Efstathios Kastritis, Argiris Symeonidis, European Journal Of Haematology	2013	40
“Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group Eirini Katodritou, Chrysanthi Vadikolia, Chrysavgi Lalagianni, Annals of Hematology Hematological MalignancyMedicineHematologyMyeloid NeoplasiaOncology	2013	39
A probable role for trail-induced apoptosis in the pathogenesis of marrow failure Theodora Kakagianni, Nikolaos Giannakoulas, Eleni Thanopoulou, Leukemia Research Bone Marrow FailureApoptosisImmunologyHematologyCell Death	2005	26
Increased Serum CA-15.3 Levels in Patients with Megaloblastic Anemia due to Vitamin B<sub>12</sub> Deficiency Argiris Symeonidis, Alexandra Kouraklis‐Symeonidis, D. Apostolopoulos, Oncology	2004	25
Addition of cyclosporin-A to chemotherapy in secondary (post-MDS) AML in the elderly. A multicenter randomized trial of the Leukemia Working Group of the Hellenic Society of Hematology Panagiota Matsouka, Maria Pagoni, Panagiotis Zikos, Annals of Hematology Hematological MalignancyOncologyLeukemia Working GroupHematologyClinical Trials	2006	20

Page 1